Erysipelas
diseaseOn this page
Summary
Erysipelas (MONDO:0001266) is a disease and 9 clinical trials. Top therapeutic interventions include amoxicillin, penicillin v, and floxacillin. A subtype of skin infection — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 9
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | erysipelas |
| Mondo ID | MONDO:0001266 |
| EFO | EFO:1001462 |
| MeSH | D004886 |
| DOID | DOID:11330 |
| ICD-10-CM | A46 |
| ICD-11 | 1651247891 |
| SNOMED CT | 44653001 |
| UMLS | C0014733 |
| MedGen | 41855 |
| Is cancer (heuristic) | no |
Data availability: 1 HPO phenotype.
Disease family
This is a subtype of skin infection. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › dermatitis › skin infection › erysipelas
Related subtypes (13): cercarial dermatitis, cutaneous diphtheria, Pthirus pubis infestation, scabies, impetigo, herpes simplex dermatitis, gonococcal keratitis, tinea infection, herpes zoster dermatitis, infection by Trypanosoma gambiense, Demodex folliculitis, furunculosis, sycosis barbae
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 9.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE4 | 4 |
| Not specified | 3 |
| PHASE2 | 2 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07104552 | PHASE4 | NOT_YET_RECRUITING | Comparing Short to Standard Amoxicillin Course for Erysipelas |
| NCT07549594 | PHASE4 | NOT_YET_RECRUITING | Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and Compression Therapy. |
| NCT01059123 | PHASE4 | TERMINATED | Short Course of Amoxicillin for Erysipelas |
| NCT02032654 | PHASE4 | TERMINATED | Duration of ANtibiotic Therapy for CEllulitis |
| NCT00893048 | PHASE2 | WITHDRAWN | The Use of Oral Steroids in the Treatment of Cellulitis |
| NCT01519778 | PHASE2 | COMPLETED | A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study |
| NCT05360914 | Not specified | RECRUITING | Hospital at Home for Elderly Acute Ill Patients |
| NCT02902822 | Not specified | COMPLETED | Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo |
| NCT03917277 | Not specified | UNKNOWN | Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| AMOXICILLIN | 4 | 1 |
| PENICILLIN V | 4 | 1 |
| FLOXACILLIN | 3 | 1 |
Related Atlas pages
- Drugs: Amoxicillin, Penicillin V, Floxacillin